Leading-Edge Glaucoma Management
October 14th 2005Participants in a Friday evening CME Symposium at The Fairmount Chicago received an update on factors that influence early diagnosis and detection of progression and therefore are crucial to effective patient management. Moderator Robert N. Weinreb, MD, University of California, San Diego, and other speakers discussed recent advances in optic nerve evaluation and the impact of central corneal thickness (CCT) and other factors on IOP measurement.
Skew deviations distinguished from oblique muscle palsy
October 12th 2005Nashville, TN—Knowledge of skew deviations and their management has changed dramatically in recent years. Skew deviations occur more commonly than previously suspected and result from lesions in the vertical vestibular ocular reflex pathway.
Sildenafil use may be linked to NAION in men
October 12th 2005Editor's Note: Howard Pomeranz, MD, describes a possible association of sildenafil and non-arteritic anterior ischemic optic neuropathy (NAION). There are several compelling parts of the argument, including temporal relationship of symptoms to drug delivery, a suggestive rechallenge history, a biologically plausible mechanism of effect, and analogy from other cases.
Ocular toxoplasmosis common cause of ocular inflammation
October 12th 2005When and how do you use laboratory testing in patients with suspected toxoplasmic retinochoroiditis? What patients require no testing? When and how do you use testing of intraocular fluids? What approach should be taken in routine clinical practice?
Chicago this year's host to 2,000 AAO scientific sessions
October 12th 2005Chicago will play host to the 109th annual meeting of the American Academy of Ophthalmology (AAO). The main meeting will run from Sunday, Oct. 15 to Tuesday, Oct. 18, but it will be preceded by 2 full days of subspecialty presentations beginning on Friday, Oct. 14. All of the subspecialty day programs and scientific program sessions will be held at the McCormick Place Convention Center on Chicago's beautiful lakefront. On Wednesday, Oct. 19, from 8 a.m. to 5:30 p.m., "The Best of the Academy in Spanish 2005" will be held in the Imperial Ballroom at the Fairmont Chicago.
Modified prolate IOL good choice for piggybacking
October 1st 2005Edina, MN—When IOL piggybacking is needed, combining the modified prolate anterior surface IOL (Tecnis, AMO) with a conventional spherical IOL is a good option because it provides patients the added benefit of improved optical performance and better quality of vision, said Y. Ralph Chu, MD.
Stay involved by overseeing procedural coding for reimbursement
October 1st 2005Must ophthalmologists understand procedural coding? Perhaps a staffer or even a computer program could do the job? Unfortunately, the answer today is that physicians need to remain involved, understanding and then overseeing the process in their offices.
IOL optic capture offers stability without capsule bag fixation
October 1st 2005Washington, DC—If capsule bag fixation is not possible, cataract surgeons have several options for IOL optic capture depending on the particular surgical needs, explained Howard V. Gimbel, MD, MPH, professor and chairman, department of ophthalmology, Loma Linda University, Loma Linda, CA.
Modified prolate IOL good choice for piggybacking
October 1st 2005Edina, MN—When IOL piggybacking is needed, combining the modified prolate anterior surface IOL (Tecnis, AMO) with a conventional spherical IOL is a good option because it provides patients the added benefit of improved optical performance and better quality of vision, said Y. Ralph Chu, MD.
Visual acuity promising after unilateral IOL implantation
October 1st 2005Orlando—Visual acuity maturation was similar in infants and young children treated with IOLs or aphakic contact lenses for unilateral congenital and developmental unilateral cataracts, according to results of a small, prospective, single-center study.
Systemic, intravitreal therapy encouraging for neovascular AMD
October 1st 2005Montreal—Favorable functional and anatomic outcomes in eyes with subfoveal neovascular age-related macular degeneration (AMD) were reported following 24 weeks in an open-label, uncontrolled clinical trial using off-label, systemic and intravitreal therapy with bevacizumab (Avastin, Genentech), a humanized full-length monoclonal anti-VEGF antibody.
Intravitreal triamcinolone helps macular diseases
October 1st 2005Montreal—Intravitreal triamcinolone acetonide (Kenalog, Bristol-Myers Squibb) is effective in the treatment of macular diseases but is associated with complications such as ocular hypertension, endophthalmitis, intraocular inflammation, and progression of cataract. While the long-term effects of the drug still need to be determined, the drug appears to be safe for treating macular diseases.
Age, family history primary factors in development of AMD
October 1st 2005Fort Lauderdale, FL—Numerous factors have been studied to determine an association with the development of age-related macular degeneration (AMD), according to Barbara Klein, MD, MPH. Family history, however, is by far the factor that stands out among the crowded arena of suspects. She reported why this is the case at the annual meeting of the Association for Research in Vision and Ophthalmology.
Minimally invasive transconjunctival surgery has advantages
October 1st 2005Montreal—Twenty-three gauge sutureless transconjunctival pars plana vitrectomy is effective for certain diseases of the posterior segment. The technique has the advantages of minimally invasive transconjunctival surgery without some of the limitations associated with 25-gauge surgery, reported Reza Iranmanesh, MD.
Confocal microscopy measures corneal nerve density
October 1st 2005Fort Lauderdale, FL—Confocal microscopy allows corneal nerve density to be measured in vivo, which has been especially helpful in identifying dramatic decreases in the nerve densities after PRK and LASIK. Using this technology, investigators can measure the increases in the densities over time following the surgeries. There are, however, artifacts that may interfere with microscopy results that must be controlled, according to William Bourne, MD.
Brazilian researchers seek to define effects of ortho-k
October 1st 2005Washington, DC—Reduction in myopia, central corneal flattening, and improvement of uncorrected visual acuity (UCVA) occur rapidly after the initiation of orthokeratology (ortho-k), but this modality also appears to result in changes in higher-order aberrations and corneal pachymetry, reported Iane G. Stillitano, MD, at the World Cornea Congress V.
HSV-1 found to be common in healthy individuals, study says
October 1st 2005New Orleans—Using highly sensitive techniques, investigators have discovered that herpes simplex virus type 1 (HSV-1) is present in a high percentage of asymptomatic individuals, said Herbert E. Kaufman, MD, Boyd professor of ophthalmology and pharmacology and experimental therapeutics, Louisiana State University Eye Center, New Orleans.
Advanced features enhance phaco safety and efficiency
October 1st 2005Washington, DC—Results of studies measuring energy used during cataract removal by phacoemulsification provide convincing evidence that the Infiniti Vision system (Alcon Laboratories) is a significant advance in optimizing surgical safety and efficiency, said Richard J. Mackool, MD, at the annual meeting of the American Society of Cataract and Refractive Surgery.
Australian kids found to have low rate of visual impairment
October 1st 2005Fort Lauderdale, FL—Australian children have a relatively low prevalence of visual impairment. The primary causes of visual problems are uncorrected astigmatism and amblyopia, according to Dana Robaei, MBBS, MPH, who spoke at the annual meeting of the Association for Research in Vision and Ophthalmology.